MAZE
Maze Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MAZE fundamentals
Maze Therapeutics (MAZE) released its earnings on Aug 12, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.77 (YoY -113.01%), beat estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.77
-113.01%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Maze Therapeutics (MAZE) key financial stats and ratios, covering profitability, financial health, and leverage.
Maze Therapeutics (MAZE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Maze Therapeutics (MAZE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Maze Therapeutics (MAZE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Maze Therapeutics (MAZE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Maze Therapeutics (MAZE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Maze Therapeutics's revenue and profit?What were the key takeaways from Maze Therapeutics’s earnings call?What is Maze Therapeutics's gross profit margin?What is Maze Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Maze Therapeutics's earnings call?What does Maze Therapeutics do and what are its main business segments?Did Maze Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Maze Therapeutics year over year?
